Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer. - Wikidata - awgldk - TriplyDB

Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.

Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.

http://www.wikidata.org/entity/Q34499632

about

FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases.

P2860

Q50673731-0B166067-283B-4EA0-BD71-7D65E67E5F5F

P2860

Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.

http://www.wikidata.org/entity/Q34499632

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Phase II trial evaluating the ...... and metastatic rectal cancer.

@ast

Phase II trial evaluating the ...... and metastatic rectal cancer.

@en

Phase II trial evaluating the ...... and metastatic rectal cancer.

@nl

type

label

Phase II trial evaluating the ...... and metastatic rectal cancer.

@ast

Phase II trial evaluating the ...... and metastatic rectal cancer.

@en

Phase II trial evaluating the ...... and metastatic rectal cancer.

@nl

prefLabel

Phase II trial evaluating the ...... and metastatic rectal cancer.

@ast

Phase II trial evaluating the ...... and metastatic rectal cancer.

@en

Phase II trial evaluating the ...... and metastatic rectal cancer.

@nl

P1433

Q34499632-87BEC984-2358-4792-8ACB-05AB74D13619

P1476

Q34499632-BB0EA330-EFE7-463B-86A8-D11CFC1B29C6

P2093

Q34499632-0446013B-2146-42DD-A8A3-CA24DE4E30D9

Q34499632-19B2509F-F900-42EC-8E40-9A8808552384

Q34499632-2FDB8F06-3D27-4273-B179-11282EE8B15A

Q34499632-62C155F9-8EBE-4DCF-B4A3-2418C6ECF26F

Q34499632-87626C3D-0E92-4AB4-B903-003534C0007E

Q34499632-8CD802A0-8006-4EAE-8674-89240CEF9783

Q34499632-953BC2A2-2794-415F-9C7B-28BCC8D2B460

Q34499632-960C354C-1CF6-4C8D-A97E-3B2C57FC95B3

Q34499632-BE2B280A-D675-4FCE-A1A8-DC7491AA72EB

Q34499632-C0D7371E-A5A3-4AD7-81AB-0F7EBE0D7AF5

P2860

Q34499632-025942FC-396C-427D-99A0-8E66A751C79A

Q34499632-054B5F6D-A45B-4B12-B103-F864803B2EAA

Q34499632-05A76D8B-6F3B-4416-A39E-42EE55D5C63B

Q34499632-0687CE40-135F-4FA4-8A51-EAE3BB036DE3

Q34499632-10863557-E146-4CBF-8864-DBD4F1365C40

Q34499632-111AF253-F214-4B5E-BC74-63A1736A392D

Q34499632-12A1E3A0-ED14-46A6-AB16-EF8FDE88511A

Q34499632-1FD55F91-0943-43AD-9D3B-20124C2C37F9

Q34499632-2081C476-1314-4478-8BE5-33AFEC1E0DF5

Q34499632-27C9805A-A646-43C5-AC22-FB2E18852081

P2888

Q34499632-68384985-030C-4A95-8127-1C0EA364EB34

P304

Q34499632-C8A4878B-13EB-476E-B1AA-F02542E9323B

P31

Q34499632-60200611-DAFA-4455-8BB5-88EBDA7F9C49

P356

Q34499632-D55F3643-FC60-4AD7-99CA-5FC933D4D0CE

P407

Q34499632-31DF4373-1EB2-4B32-BEFF-1A7BC1A50693

P433

Q34499632-6ABE5418-3B40-48DA-AAE2-13C8DAE69BF2

P478

Q34499632-D34DFE45-65CB-41F6-BF47-CCD07719222F

P50

Q34499632-50CD71B5-8715-45F9-8780-5FD3B0EB690C

Q34499632-BB9A2F5E-78C4-49FF-9D9D-40E5A1DB890D

P577

Q34499632-1C9F5E4E-F8E4-4C2C-A3AC-C837B242CBCB

P5875

Q34499632-154820C9-90B5-45E5-9F4D-C21F01CB9767

P6179

Q34499632-593BEEEA-5912-48DC-8BCE-36B2CA379712

P698

Q34499632-1118A546-FC01-454E-B36F-99994BBB3F14

P921

Q34499632-22E2843F-2A8F-4C71-8AA4-F52A454C47EB

Q34499632-A6845EEC-C9F0-4D6E-9C70-8E09BFF3749B

P932

Q34499632-F86BECA5-6527-4D6A-A296-DC4450DBD11B

P356

P1433

British Journal of Cancer

P1476

Phase II trial evaluating the ...... and metastatic rectal cancer.

@en

P2093

A Heriot

http://www.w3.org/2001/XMLSchema#string

B McClure

http://www.w3.org/2001/XMLSchema#string

J McKendrick

http://www.w3.org/2001/XMLSchema#string

J R MacKay

http://www.w3.org/2001/XMLSchema#string

J Zalcberg

http://www.w3.org/2001/XMLSchema#string

M Bressel

http://www.w3.org/2001/XMLSchema#string

M Michael

http://www.w3.org/2001/XMLSchema#string

M Steel

http://www.w3.org/2001/XMLSchema#string

P Cooray

http://www.w3.org/2001/XMLSchema#string

S Chander

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer.

Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer.

Determination of tumor kinetics: strategies for the delivery of radiotherapy and chemotherapy.

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.

Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis.

Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi

Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.

P2888

P304

1924-1931

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2014.487

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Rodney J. Hicks

P577

2014-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265559550

http://www.w3.org/2001/XMLSchema#string

P6179

1046108316

http://www.w3.org/2001/XMLSchema#string

P698

25211659

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

chemoradiotherapy

P932

4229632

http://www.w3.org/2001/XMLSchema#string